05:32 AM EDT, 10/27/2025 (MT Newswires) -- Evotec (EVO) said Monday it has received a $25 million payment from Bristol Myers Squibb ( BMY ) for scientific progress achieved under the companies' neuroscience partnership.

The payment will help advance the companies' joint pipeline of programs aimed at tackling neurogenerative diseases.

Evotec shares were up 1.5% in recent premarket activity, while Bristol Myers rose 0.1%.